Richard A. Fair
Insider Reports History
- Location
- Houston, TX
- Signature
- /s/ Ben Hohl, by power of attorney
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Richard A. Fair:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Enliven Therapeutics, Inc. | PRESIDENT AND CEO, Director | Stock Option (right to buy) | 875,000 | 11 Dec 2025 | Direct | ||
| BELLICUM PHARMACEUTICALS, INC | President and CEO, Director | Stock Option (right to buy) | 400,000 | 15 Aug 2022 | Direct | ||
| Clovis Oncology, Inc. | Director | Stock Option (right to buy) | 42,223 | 10 Jun 2021 | Direct |
Insider Reports Filed by Richard A. Fair
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ELVN | Enliven Therapeutics, Inc. | 11 Dec 2025 | 1 | $0 | 4 | PRESIDENT AND CEO, Director | 12 Dec 2025, 18:31 |
| ELVN | Enliven Therapeutics, Inc. | 11 Dec 2025 | 0 | $0 | 3 | PRESIDENT AND CEO, Director | 12 Dec 2025, 18:30 |
| /report/000162828022023030-fair-richard-a-2022-08-15 | BELLICUM PHARMACEUTICALS, INC | 15 Aug 2022 | 1 | +$576,000 | 4 | President and CEO, Director | 16 Aug 2022, 17:04 |
| /report/000162828021017225-fair-richard-a-2021-08-16-restatement | BELLICUM PHARMACEUTICALS, INC | 16 Aug 2021 | 1 | $0 | 4/A | President and CEO, Director | 18 Aug 2021, 12:21 |
| /report/000089924321023392-fair-richard-a-2021-06-10 | Clovis Oncology, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 11 Jun 2021, 20:48 |